The New England Journal of Medicine recently reported that the drug interleukin-12/23 monoclonal antibody demonstrated promising results for the treatment and management of psoriasis.
Patients who took the highest dose of the interleukin drug reported the greatest improvements in the red, scaly, and flaking patches which are characteristic of this skin disease.
Sea whip (formally known as pseudopterogorgia elisabethae) extract is a soft coral found in the Caribbean. Clinical studies have shown that substances in sea whip can be used to reduce redness and inflammation of the skin. They also have been shown to help skin cells repair themselves, and have been shown useful in the treatment of sunburn, cuts, and of rashes and other irritation to the skin.
The Dead Sea has long been hailed as one of the richest sources of salt and mud. It may not sound like much, but Dead Sea Salt and Dead Sea Mud are prized all over the world for their health and beauty boosting properties. History suggests that Cleopatra regularly applied Dead Sea Mud to keep herself young and beautiful.
While much has been written about the skin benefits of Dead Sea salts, what about the mud? What is so great about that?
People who suffer from psoriasis may be at greater risk of heart attacks, according to a new study recently published in the Journal of the American Medical Association.
This link seems to be particularly significant in young adults with severe psoriasis, who have a 29% greater risk of suffering a heart attack compared to those of the same age who do not have psoriasis. These results hold true even after adjustments for cardiovascular risk factors such as smoking and high blood pressure.
German researchers have recently studied four treatments for intertriginous psoriasis, an inflammatory skin disease which infects skin folds of the underarms, breasts, groin, buttocks, and genitals.
Usually treated with topical corticosteroids, intertriginous psoriasis leads to significant physical and emotional discomfort for those who suffer from it. Topical corticosteroids may have unwelcome side effects if used for a long time, which is why new treatments are being studied.
Two treatments for chronic plaque psoriasis were tested head to head in the UK. Researchers examined the effects of Psoralen-UV-A (PUVA) therapy against narrowband UV-B (NB-UVB) therapy. PUVA was found to be more effective.
